NurExone Total Stockholder Equity from 2010 to 2024

Stocks . Canada . 
Stock . NurExone Biologic
NRX Stock   0.70  0.04  5.41%   
NurExone Biologic Total Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Total Stockholder Equity will likely drop to about 179.6 K in 2024. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
189 K
Current Value
179.6 K
Quarterly Volatility
442.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NurExone Biologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NurExone Biologic's main balance sheet or income statement drivers, such as Net Interest Income of 44.1 K, Interest Expense of 2.9 K or Selling General Administrative of 2.7 M, as well as many indicators such as . NurExone financial statements analysis is a perfect complement when working with NurExone Biologic Valuation or Volatility modules.
  
This module can also supplement various NurExone Biologic Technical models . Check out the analysis of NurExone Biologic Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NurExone Stock Analysis

When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY